We found that prenatal exposure to low doses of BPA promoted mammary tumor development in this clinically relevant model, which was preceded with significant alterations in epithelial cell proliferation, morphogenesis, and signal transduction in ER and erbB2 pathways in premalignant mammary tissues. The gene discussed is ERBB2; the disease is breast cancer.